Novartis chief says Trump visa restrictions sour US hiring plans; Parexel and Sanofi to develop wearable devices
→ Don’t look for Novartis CEO Joe Jimenez to add many new jobs in the US anytime soon. In recent interviews the pharma chief says that new visa restrictions advanced by the Trump administration has soured his appetite for any expansion in the US. The company has already felt the effects on hiring foreign nationals. “This makes the country a less attractive location for investment…by contrast, Switzerland and Europe will become more attractive,” he said. Jimenez was one of several industry leaders to meet with the president in January about decreasing drug prices and increasing jobs in the United States.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.